An under-wraps Silicon Valley startup that describes itself as “the cold cure for brain injury” has secured $1.5 million in financing.
NeuroSave Inc. CEO Seth Rodgers said the company still has a little ways to go before it can begin talking in detail about its product. But a U.S. Patent and Trademark Office record filed by the company in 2010 refers to a medical apparatus used to induce therapeutic hypothermia by circulating cooling liquid in and around the body through tubes in the esophagus, trachea or pharynx.
Research has found that lowering a patient’s body temperature soon after cardiac arrest or traumatic brain injury can be a way to slow brain cells’ metabolism and prevent life-threatening brain damage. Hypothermia can be induced externally with the use of ice packs or cooling blankets, or invasively through cooling catheters or ice-cold IV saline.
As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities
In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play.
There are a few other companies innovating in this space, including Cryothermic Systems, Life Recovery Systems and BeneChill, a company that’s partnered with Physio-Control and has the CE Mark for a fast-evaporating liquid that cools the brain when it’s squirted up the nose.